Sheng Cao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sheng Cao has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Guang Yang
Nankai University
4 shared publications - Chen Li
The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300071, P. R. China
2 shared publications - Feng Li
College of Food Science and Pharmaceutical Engineering, Zaozhuang University, Zaozhuang 277160, China
2 shared publications Lan Ma
The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy
2 shared publicationsMingming Wei
The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy
2 shared publicationsYilei Huang
The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University
2 shared publications
Latest Publications
- Open Access
Improvement in the Thermal Stability of IsMHETase by Sequence and Structure-Guided Calculation
In the degradation of poly(ethylene terephthalate) (PET), mono(2-hydroxyethyl) terephthalate (MHET) hydrolase (IsMHETase) plays a crucial role in the complete degradation of PET. Although IsMHETase was discovered concurrently with IsPETase, its structural and functional properties are not well understood. To enhance the thermal stability of IsMHETase, we selected six homologous proteins that share the closest evolutionary relationship for structure-based protein rational design, all exhibiting over 60% amino acid sequence identity with IsMHETase. Using FireProt, PROSS, and Consensus analysis, we identified the key mutation sites of IsMHETase. Sequence and structural analyses indicate that, among these seven proteins, all amino acids within 5 Å of the substrate-binding site are identical, with the exception of Ser131 and Phe415. Additionally, the amino acids within a 4 Å range of the catalytic triad are nearly identical. Through integrated free energy calculations, phylogenetic tree analysis, sequence analysis, and conservation analysis, we have identified a variant with four key mutations (termed IsMHETase-M1: N156G, T159V, E110A, A493P) that exhibits improved thermal stability. The selection of mutations during the protein modification process often requires considerable time. Our predictions have established a foundation for the rational design of IsMHETase and its homologous proteins.
Open AccessImprovement in the Thermal Stability of IsMHETase by Sequence and Structure-Guided Calculation
In the degradation of poly(ethylene terephthalate) (PET), mono(2-hydroxyethyl) terephthalate (MHET) hydrolase (IsMHETase) plays a crucial role in the complete degradation of PET. Although IsMHETase was discovered concurrently with IsPETase, its structural and functional properties are not well understood. To enhance the thermal stability of IsMHETase, we selected six homologous proteins that share the closest evolutionary relationship for structure-based protein rational design, all exhibiting over 60% amino acid sequence identity with IsMHETase. Using FireProt, PROSS, and Consensus analysis, we identified the key mutation sites of IsMHETase. Sequence and structural analyses indicate that, among these seven proteins, all amino acids within 5 Å of the substrate-binding site are identical, with the exception of Ser131 and Phe415. Additionally, the amino acids within a 4 Å range of the catalytic triad are nearly identical. Through integrated free energy calculations, phylogenetic tree analysis, sequence analysis, and conservation analysis, we have identified a variant with four key mutations (termed IsMHETase-M1: N156G, T159V, E110A, A493P) that exhibits improved thermal stability. The selection of mutations during the protein modification process often requires considerable time. Our predictions have established a foundation for the rational design of IsMHETase and its homologous proteins.
- 2 February 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
Identification of a Potent and Selective CDK9 Degrader as a Targeted Therapeutic Option for the Treatment of Small-Cell Lung Cancer
Small-cell lung cancer (SCLC) represents a significant public health challenge due to its increasing incidence and high mortality. Most SCLC patients are diagnosed at advanced stages, and there are limited effective targeted therapies available. In this study, a potent and selective CDK9 degrader, C3, was developed through PROTAC modification of the CDK9 inhibitor, AT-7519. C3 effectively induced apoptosis in various SCLC cell lines at low nanomolar concentrations and demonstrated favorable in vivo tolerance and adequate oral bioavailability. Notably, PROTAC C3 significantly reduced the proliferation of primary tumor samples from patients in mini-PDX models. Our findings indicate that the targeted degradation of CDK9 could become a viable strategy for treating SCLC, highlighting its potential therapeutic value. Additionally, this research offers a general structural optimization and evaluation strategy to improve the degradative selectivity, metabolic stability, and oral availability of PROTAC molecules.
- 2 February 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
Identification of a Potent and Selective CDK9 Degrader as a Targeted Therapeutic Option for the Treatment of Small-Cell Lung Cancer
Small-cell lung cancer (SCLC) represents a significant public health challenge due to its increasing incidence and high mortality. Most SCLC patients are diagnosed at advanced stages, and there are limited effective targeted therapies available. In this study, a potent and selective CDK9 degrader, C3, was developed through PROTAC modification of the CDK9 inhibitor, AT-7519. C3 effectively induced apoptosis in various SCLC cell lines at low nanomolar concentrations and demonstrated favorable in vivo tolerance and adequate oral bioavailability. Notably, PROTAC C3 significantly reduced the proliferation of primary tumor samples from patients in mini-PDX models. Our findings indicate that the targeted degradation of CDK9 could become a viable strategy for treating SCLC, highlighting its potential therapeutic value. Additionally, this research offers a general structural optimization and evaluation strategy to improve the degradative selectivity, metabolic stability, and oral availability of PROTAC molecules.
- 23 January 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 61 (16) , 3359-3362
Solvent-controlled silver catalyzed radical transformation of α-imino-oxy acids with cyclic aldimines
A silver-catalyzed cross coupling of cyclic aldimines and α-imino-oxy acids has been developed. The solvent-dependent reaction could selectively deliver either cyclic imine moiety retained nitriles or ring-opened oxonitriles in moderate yields.
- 23 January 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 61 (16) , 3359-3362
Solvent-controlled silver catalyzed radical transformation of α-imino-oxy acids with cyclic aldimines
A silver-catalyzed cross coupling of cyclic aldimines and α-imino-oxy acids has been developed. The solvent-dependent reaction could selectively deliver either cyclic imine moiety retained nitriles or ring-opened oxonitriles in moderate yields.
- 3 January 2025
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 12 (5) , 1550-1555
Metal-free synthesis of carboxamides via the Lossen rearrangement
A novel and efficient method for synthesizing carboxamides has been developed, utilizing a base-promoted Lossen rearrangement of hydroxylamine derivatives. In these reactions, the hydroxylamine derivatives are bench-top stable and easy to handle, allowing them to smoothly replace highly toxic isocyanate reagents by generating isocyanates in situ. This approach facilitates the straightforward formation of C–P, C–C, or C–N bonds. Furthermore, the mild reaction conditions, straightforward operational procedure, and broad substrate scope render this protocol highly practical and attractive.
- 3 January 2025
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 12 (5) , 1550-1555
Metal-free synthesis of carboxamides via the Lossen rearrangement
A novel and efficient method for synthesizing carboxamides has been developed, utilizing a base-promoted Lossen rearrangement of hydroxylamine derivatives. In these reactions, the hydroxylamine derivatives are bench-top stable and easy to handle, allowing them to smoothly replace highly toxic isocyanate reagents by generating isocyanates in situ. This approach facilitates the straightforward formation of C–P, C–C, or C–N bonds. Furthermore, the mild reaction conditions, straightforward operational procedure, and broad substrate scope render this protocol highly practical and attractive.
- 25 October 2021
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 64 (22) , 16497-16511
Proteolysis-Targeting Chimera (PROTAC) Modification of Dovitinib Enhances the Antiproliferative Effect against FLT3-ITD-Positive Acute Myeloid Leukemia Cells
Acute myeloid leukemia (AML) refers to one of the most lethal blood malignancies worldwide. FLT3-ITD mutation is recognized as the most common one that predicted a poorer prognosis. There have been many prominent FLT3-ITD inhibitors approved by the FDA for clinical therapies. However, as impacted by undesirable off-target effects, differentiated metabolic issues, and clinical drug resistance problems, it remains challenging to discover alternative and promising solutions for treating FLT3-ITD+ AML. In this study, dovitinib was chemically modified and converted into CRBN-recruiting PROTACs. Two active compounds were identified, which showed enhanced antiproliferative effects against FLT3-ITD+ AML cells, both in vitro and in vivo. As demonstrated from further biological evaluation, the compounds could induce the degradation of the FLT3-ITD and KIT proteins in a ubiquitin–proteasome-dependent manner and completely block their downstream signaling pathway. The findings of this study would provide another promising strategy to develop novel therapies for FLT3-ITD+ AML.
- 25 October 2021
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 64 (22) , 16497-16511
Proteolysis-Targeting Chimera (PROTAC) Modification of Dovitinib Enhances the Antiproliferative Effect against FLT3-ITD-Positive Acute Myeloid Leukemia Cells
Acute myeloid leukemia (AML) refers to one of the most lethal blood malignancies worldwide. FLT3-ITD mutation is recognized as the most common one that predicted a poorer prognosis. There have been many prominent FLT3-ITD inhibitors approved by the FDA for clinical therapies. However, as impacted by undesirable off-target effects, differentiated metabolic issues, and clinical drug resistance problems, it remains challenging to discover alternative and promising solutions for treating FLT3-ITD+ AML. In this study, dovitinib was chemically modified and converted into CRBN-recruiting PROTACs. Two active compounds were identified, which showed enhanced antiproliferative effects against FLT3-ITD+ AML cells, both in vitro and in vivo. As demonstrated from further biological evaluation, the compounds could induce the degradation of the FLT3-ITD and KIT proteins in a ubiquitin–proteasome-dependent manner and completely block their downstream signaling pathway. The findings of this study would provide another promising strategy to develop novel therapies for FLT3-ITD+ AML.
- 29 September 2021
- Published by Georg Thieme Verlag KG in Synlett
- Vol. 32 (20) , 2063-2066
Diastereoselective Pd-Catalyzed Decarboxylative Allylation To Construct Quaternary Stereocenters Using Sulfinimine as the Directing Group
A robust Pd(0)-catalyzed decarboxylation alkylation has been developed to construct quaternary stereocenters through the use of chiral tert-butanesulfinamide as the directing group. This strategy provides a simple and efficient route to the construction of quaternary chiral centers at the α-position of chiral sulfinamides, with high diastereoselectivities and high yields.
- 29 September 2021
- Published by Georg Thieme Verlag KG in Synlett
- Vol. 32 (20) , 2063-2066
Diastereoselective Pd-Catalyzed Decarboxylative Allylation To Construct Quaternary Stereocenters Using Sulfinimine as the Directing Group
A robust Pd(0)-catalyzed decarboxylation alkylation has been developed to construct quaternary stereocenters through the use of chiral tert-butanesulfinamide as the directing group. This strategy provides a simple and efficient route to the construction of quaternary chiral centers at the α-position of chiral sulfinamides, with high diastereoselectivities and high yields.
- 16 September 2021
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 8 (22) , 6182-6186
A robust and facile method for desulfonation to amines
In this study, a robust and facile method for desulfonation to achieve secondary amines is demonstrated. Diphenylphosphine (Ph2PH) was shown to significantly expedite the cleavage of sulfonamides under basic conditions. Aromatic and aliphatic sulfonamides were cleanly converted, with a rapid reaction time, into the required amines with good to excellent chemical yields. Moreover, the functional groups tested were generally well tolerated.
- 16 September 2021
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 8 (22) , 6182-6186
A robust and facile method for desulfonation to amines
In this study, a robust and facile method for desulfonation to achieve secondary amines is demonstrated. Diphenylphosphine (Ph2PH) was shown to significantly expedite the cleavage of sulfonamides under basic conditions. Aromatic and aliphatic sulfonamides were cleanly converted, with a rapid reaction time, into the required amines with good to excellent chemical yields. Moreover, the functional groups tested were generally well tolerated.